Skip to main content

Table 4 Demographic, behavioural and analytical characteristics of the Metabolic Syndrome subjects

From: The prevalence of the metabolic syndrome in Portugal: the PORMETS study

 

With MetS

Without MetS

Prevalence ratio (95%CI) a

p

Gender Men

656 (39.0)

1026 (61.0)

*

 

Women

938 (40.7)

1367 (59.3)

1.15 (1.07–1.23)

< 0.001

Age [years, n (%)] 18–30

21 (5.0)

402 (95.0)

*

 

31–40

87 (16.0)

458 (84.0)

3.20 (2.02–5.06)

< 0.001

41–50

222 (30.5)

506 (69.5)

6.09 (3.96–9.37)

< 0.001

51–60

391 (47.3)

435 (52.7)

9.52 (6.23–14.53)

< 0.001

61–70

467 (58.5)

331 (41.5)

11.91 (7.82–18.15)

< 0.001

> 70

406 (60.9)

261 (39.1)

12.40 (8.14–18.90)

<0.001

Education [years, n (%)] 0–4

1054 (53.2)

929 (46.8)

1.11 (0.97–1.28)

0.137

5–12

415 (27.1)

1116 (72.9)

1.03 (0.89–1.20)

0.678

> 12

125 (26.4)

348 (73.6)

*

 

Marital status Single/divorced/widower

377 (34.6)

713 (65.4)

*

 

Married

1211 (41.9)

1676 (58.1)

0.99 (0.92–1.08)

0.869

Occupation [n (%)] Student

2 (2.4)

81 (97.6)

0.54 (0.14–2.09)

0.372

Unemployed

72 (36.2)

127 (63.8)

1.26 (1.03–1.53)

0.024

Housewife

195 (48.4)

208 (51.6)

1.23 (1.05–1.43)

0.010

Retired

703 (58.4)

500 (41.6)

1.16 (1.00–1.35)

0.046

Blue-collar

251 (29.4)

602 (70.6)

1.03 (0.81–1.20)

0.684

White-collar

193 (24.1)

607 (75.9)

*

 

Smoking status [n (%)] Smoker

137 (24.2)

429 (75.8)

0.85 (0.73–0.98)

0.027

Ex-smoker

245 (42.8)

327 (57.2)

1.00 (0.90–1.11)

0.977

Non-smoker

1198 (43.1)

1580 (56.9)

*

 

Physical exercise [n (%)] No

1232 (42.9)

1638 (57.1)

1.18 (1.08–1.29)

<0.001

Yes

338 (31.9)

722 (68.1)

*

 

Residence [n (%)] Non-urban

835 (43.4)

1087 (56.6)

1.13 (1.05–1.20)

0.001

Urban

759 (36.8)

1306 (63.2)

*

 

Weight [kg, Mean (SE)]

78.5 (13.6)

68.1 (12.3)

1.00 (1.00–1.00)

<0.001

Body mass index [kg/m2, Mean (SE)]

30.0 (4.4)

25.6 (4.0)

1.09 (1.08–1.10)

<0.001

Waist circumference [cm, Mean (SE)]

101.4 (10.1)

88.2 (11.0)

1.00 (1.00–1.00)

<0.001

Hip circumference [cm, Mean (SE)]

108.2 (9.4)

100.5 (8.5)

1.00 (1.00–1.00)

<0.001

Total cholesterol [mg/dL, Mean (SE)]

211.6 (43.0)

207.1 (41.1)

1.04 (0.96–1.13)

0.305

HDL cholesterol [mg/dL, Mean (SE)]

43.2 (11.0)

51.0 (12.5)

0.81 (0.65–1.06)

0.067

Triglycerides [mg/dL, Mean (SE)]

159.0 (86.4)

99.8 (46.3)

1.28 (1.24–1.32)

<0.001

Glucose [mg/dL, Mean (SE)]

105.5 (35.7)

83.1 (16.1)

1.11 (1.07–1.15)

<0.001

Insulin [μU/ml, Median (P25 -P75)]

9.99 (6.80–14.30)

6.50 (4.40–9.50)

1.03 (1.03–1.04)

<0.001

hs-CRP [mg/L, Median (P25 -P75)]

0.22 (0.10–0.47)

0.13 (0.06–0.29)

1.00 (1.00–1.00)

0.107

HOMA –IR [Median (P25 -P75)]

2.43 (1.58–3.72)

1.32 (0.86–1.96)

1.09 (1.07–1.10)

<0.001

Diabetes [n (%)]

451 (76.8)

136 (23.2)

1.65 (1.55–1.75)

< 0.001

Previous myocardial infarction [n (%)]

115 (69.3)

51 (30.7)

1.26 (1.14–1.40)

<0.001

Previous stroke [n (%)]

138 (63.3)

80 (36.7)

1.19 (1.07–1.31)

0.001

  1. MetS: metabolic syndrome (as defined by HARM2009).
  2. The PORMETS study was conducted in mainland Portugal from February 2007 to July 2009.
  3. aPrevalence ratio adjusted for sex and age.
  4. *Reference class.